Table 2.

Period prevalence of single comorbidities in T2D patients (in percent) by age group, sex and time period.

Age	Comorbidity	Males			Females
		2005–2007	2010–2012	2015–2017	2005–2007	2010–2012	2015–2017
18–45 years	Myocardial infarction	1.10	1.02	1.55	0.45	0.35	0.29
	Angina pectoris	2.25	2.00	1.61	1.26	1.22	0.59
	Stroke	0.74	0.59	0.66	0.59	0.43	0.49
	Hypertension	40.58	48.90	55.35	36.03	41.15	45.87
	Hyperlipidemia	30.61	32.67	36.15	20.51	21.54	23.05
	Cardiac insufficiency	2.21	2.63	3.04	0.93	1.27	2.14
	Retinopathy	2.19	2.00	2.82	2.05	1.59	2.29
	Nephropathy	3.16	4.32	5.79	2.60	3.32	4.33
	Polyneuropathy	7.23	8.81	9.98	7.17	9.92	10.60
46–64 years	Myocardial infarction	2.76	2.88	3.04	1.18	1.07	1.17
	Angina pectoris	5.80	5.56	4.66	3.87	3.22	2.64
	Stroke	2.13	2.06	2.15	1.31	1.30	1.20
	Hypertension	66.44	74.41	81.10	70.27	76.86	81.95
	Hyperlipidemia	43.79	50.20	55.89	37.77	43.52	48.36
	Cardiac insufficiency	7.40	9.22	11.78	6.21	6.86	8.06
	Retinopathy	4.08	4.46	5.55	4.19	4.29	5.36
	Nephropathy	6.62	9.63	13.09	4.92	7.39	10.93
	Polyneuropathy	12.61	18.28	22.02	13.55	18.49	22.80
65 + years	Myocardial infarction	4.54	4.70	4.47	3.21	3.08	2.70
	Angina pectoris	8.93	8.83	7.24	6.73	6.45	5.18
	Stroke	5.34	5.06	5.04	5.13	4.73	4.46
	Hypertension	84.91	95.71	100	90.79	98.91	100
	Hyperlipidemia	46.57	58.35	66.61	44.75	55.51	62.60
	Cardiac insufficiency	25.88	29.17	34.80	33.89	33.50	36.56
	Retinopathy	6.02	7.35	9.71	6.21	7.34	9.21
	Nephropathy	19.36	27.67	38.22	15.86	24.09	36.03
	Polyneuropathy	15.49	23.51	32.74	15.99	23.59	32.55